Home > Inhibitors & Agonists > Others

Others

You can also try the following methods, and our professionals will serve you Customized Consultation
Cat. No. Product Name Field of Application Chemical Structure
DCC5141 Thpp-2 Novel phosphodiesterase 10A (PDE10A) inhibitor for treatment of schizophrenia
DCC5142 Thpp-4 Phosphodiesterase 10A (PDE10A) inhibitor
DCC5143 Thr101 Novel dose-dependent inhibitor of HDAC1, HDAC3, HDAC4, HDAC5, HDAC6, HDAC7, HDAC8, and HDAC9; NOX Inhibitor
DCC5144 Thrombin-in-3g Novel selective thrombin inhibitor, inducing conformational allostery
DCC5145 Thrx160209 Novel multivalent ligand that bridges the allosteric and orthosteric binding sites of the M2 muscarinic receptor
DCC5146 Tiagabine Anti-epileptic and anticonvulsant agent, acting as a selective GABA reuptake inhibitor
DCC5147 Tiancimycin Anthraquinone-fused enediyne antitumor agent for development of antibody-drug conjugates (ADCs)
DCC5148 Tiemonium Iodide Muscarinic receptor antagonist, anticholinergic,and parasympatholytic
DCC5149 Tigilanol Tiglate Natural anticancer agent fortreatment of mast cell tumor (MCT)
DCC5150 Tillman Reagent Widely used oxidation-reduction indicator
DCC5151 Tilmicosin Phosphate Macrolide antibiotic for the treatment of bovine respiratory disease and ovine respiratory disease associated with Mannheimia (Pasteurella) haemolytica
DCC5152 Tilorone Dihydrochloride Antiviral, antineoplastic, and anti-inflammatory agent; Orally active interferon inducer, inhibiting Ebola virus (EBOV)
DCC5153 Tinostamustine Hydrochloride Novel pan-histone-deacetylase inhibitor with alkylating activity
DCC5154 Tinyatoxin Neurotoxin, acting via vanilloid receptors of sensory nerves
DCC5155 Tioxolone Novel hepcidin antagonist
DCC5156 tipp-204 hPPAR
DCC5157 tipp-401 Dual PPA
DCC5158 tipp-703 hPPAR-pan agonist
DCC5159 Tiracizine Hydrochloride Anti-arrhythmia agent
DCC5160 Tl13-117 Novel AC220-based FLT3 degrader
DCC5161 Tl13-149 Novel AC220-based FLT3 degrader
DCC5162 Tli3-12 The first small molecule degrader, inducing anaplastic lymphoma kinase (ALK) degradation, including in non-small-cell lung cancer (NSCLC), anaplastic large-cell lymphoma (ALCL), and neuroblastoma (NB) cell lines
DCC5163 Tli3-i12 The first small molecule degrader, inducing anaplastic lymphoma kinase (ALK) degradation, including in non-small-cell lung cancer (NSCLC), anaplastic large-cell lymphoma (ALCL), and neuroblastoma (NB) cell lines
DCC5164 Tlk19781 Novel Insulin Receptor Modulator
DCC5165 tlr4-in-c35 Novel Toll-Like Receptor 4 (TLR4) Inhibitor
DCC5166 Tlr7/8-in-cmpd2 Novel potent and selective dual TLR7/8 inhibitor
DCC5167 Tlr8-in-5 Novel toll-like receptor 8 (TLR8) inhibitor, potently and selectively reducing TLR8-mediated signaling
DCC5168 Tls-in-5 The first small molecule inhibitor of translesion synthesis (TLS) that target Rev1-CT
DCC5169 Tm2-119 Potent histone methyltransferase inhibitor with rapid antimalarial activity against all blood stage forms in Plasmodium falciparum
DCC5170 Tm-233 Novel inhibitor of both JAK/STAT and proteasome activities, inducing cell death in myeloma cells

Customized Consultation X

Your information is safe with us. * Required Fields.

Your name
Company
Email
Procuct Name
Cat. No.
Remark
Verification code
Please fill out the characters in the picture
X
>